PUBLICATION
Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy
- Authors
- Schiavone, M., Zulian, A., Menazza, S., Petronilli, V., Argenton, F., Merlini, L., Sabatelli, P., Bernardi, P.
- ID
- ZDB-PUB-170914-4
- Date
- 2017
- Source
- Pharmacological research 125(Pt B): 122-131 (Journal)
- Registered Authors
- Argenton, Francesco, Schiavone, Marco
- Keywords
- Duchenne Muscular Dystrophy, cyclophilin, mitochondria, permeability transition, respiration
- MeSH Terms
-
- Animals
- Cell Respiration/drug effects
- Cells, Cultured
- Cyclosporine/pharmacology*
- Cyclosporine/therapeutic use
- Disease Models, Animal
- Humans
- Membrane Potential, Mitochondrial/drug effects
- Mitochondria/drug effects*
- Mitochondria/metabolism
- Mitochondria/physiology
- Muscle Cells/drug effects
- Muscle Cells/metabolism
- Muscle Cells/physiology
- Muscular Dystrophy, Animal/drug therapy
- Muscular Dystrophy, Animal/metabolism*
- Muscular Dystrophy, Duchenne/drug therapy
- Muscular Dystrophy, Duchenne/metabolism*
- Oxygen Consumption/drug effects
- Zebrafish
- PubMed
- 28899790 Full text @ Pharmacol. Res.
Citation
Schiavone, M., Zulian, A., Menazza, S., Petronilli, V., Argenton, F., Merlini, L., Sabatelli, P., Bernardi, P. (2017) Alisporivir rescues defective mitochondrial respiration in Duchenne muscular dystrophy. Pharmacological research. 125(Pt B):122-131.
Abstract
Duchenne muscular dystrophy (DMD) is a severe muscle disease of known etiology without effective, or generally applicable therapy. Mitochondria are affected by the disease in animal models but whether mitochondrial dysfunction is part of the pathogenesis in patients remains unclear. We show that primary cultures obtained from muscle biopsies of DMD patients display a decrease of the respiratory reserve, a consequence of inappropriate opening of the permeability transition pore (PTP). Treatment with the cyclophilin inhibitor alisporivir - a cyclosporin A derivative that desensitizes the PTP but does not inhibit calcineurin - largely restored the maximal respiratory capacity without affecting basal oxygen consumption in cells from patients, thus reinstating a normal respiratory reserve. Treatment with alisporivir, but not with cyclosporin A, led to a substantial recovery of respiratory function matching improved muscle ultrastructure and survival of sapje zebrafish, a severe model of DMD where muscle defects are close to those of DMD patients. Alisporivir was generally well tolerated in HCV patients and could be used for the treatment of DMD.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping